Omeros | OMER - Action





Action Changement Date
Adma Biologics USD 206.46M 9.8M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Cytokinetics USD 0 0 2023-12
Gilead Sciences USD 1.78B 40M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.07M 11.1M 2025-12
Knight Therapeutics CAD 95.4M 2.91M 2024-03
MacroGenics USD 7.91M 840K 2025-12
Omeros USD 712K 266K 2021-09
Pacira USD 152.86M 4.82M 2025-12
Pfizer USD 11.47B 201M 2025-09
Rockwell Medical USD 4.16M 885K 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12